4//SEC Filing
ELAN PHARMACEUTICAL INVESTMENTS LTD 4
Accession 0000950162-04-000476
CIK 0000810084other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:38 PM ET
Size
11.4 KB
Accession
0000950162-04-000476
Insider Transaction Report
Form 4
ELAN CORP PLC
10% Owner
Transactions
- Sale
Common Stock
2004-04-06$3.00/sh−30,000$90,000→ 2,449,936 total(indirect: I) - Sale
Common Stock
2004-04-05$3.00/sh−65,000$195,000→ 2,479,936 total(indirect: I)
Footnotes (1)
- [F1]The securities are beneficially owned indirectly by Elan Corporation, plc and by its wholly-owned subsidiary, Elan International Services, Ltd., and directly by Elan Pharmaceutical Investments, Ltd., a wholly-owned subsidiary of Elan International Services, Ltd.
Issuer
BIOJECT MEDICAL TECHNOLOGIES INC
CIK 0000810084
Entity typeother
Related Parties
1- filerCIK 0001279105
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 4:38 PM ET
- Size
- 11.4 KB